RhoA has been implicated in the progression and metastasis of various cancers. Aberrant RhoA signaling can lead to uncontrolled cell division, resistance to apoptosis, and enhanced invasiveness. The dysregulation of RhoA and its downstream effectors is often observed in many cancer types, including breast, lung, and colorectal cancers.
